|
|
 |
| |
April 5, 2004
Torii Pharmaceutical Co., Ltd.
Aventis Behring Japan Co., Ltd. |
|
|
| Transfer of Marketing Right for TachoComb |
|
Torii Pharmaceutical Co., Ltd. (Torii) [head office: Tokyo, president: Norihiko Matsuo] and Aventis Behring Japan Co., Ltd. (ABJ) [head office: Tokyo, president: Hermann Strenger] have agreed that Torii will transfer the marketing right for TachoComb, a biological tissue conglutination dressing sheet, to ABJ.
Upon completion of the proceedings for transferring the import approval of TachoComb, ABJ will assume responsibility for the product and provide relevant information (in October according to the present plan). Torii will continue to perform these activities until that time.
This transfer of marketing right for TachoComb will be realized as a result of the concordance of Torii's business policy of reviewing product strategies for blood products and ABJ's business policy of further reinforcement of product lines in its business specializing in blood products.
[Overview of the product]
| Product name: |
TachoComb, a biological tissue conglutination dressing sheet |
| Importer: |
Torii Pharmaceutical Co., Ltd. |
| Affiliate (manufacturer): |
Nycomed Austria GmbH |
| Date of launch: |
April 1999 |
(Reference data)
Profile of Torii Pharmaceutical Co., Ltd.
| Date of establishment: |
November 1921 |
| Address of the head office: |
4-1 Nihonbashi-Honcho 3-chome, Chuo-ku, Tokyo |
| Representative: |
Norihiko Matsuo, President and Representative Director |
| Capital: |
5,190 million yen (as of the end of March 2003) |
| Description of business: |
Production, sales, import and export of pharmaceutical products, medical devices, and reagents, and real estate (rental) business |
Profile of Aventis Behring Japan Co., Ltd.
| Date of establishment: |
February 2000 |
| Address of the head office: |
1-13-1, Kachidoki, Chuo-ku, Tokyo |
| Representative: |
Hermann Strenger, Representative Director and President |
| Capital: |
50 million yen (as of the end of March 2003) |
| Description of business: |
Manufacture, distribution and import of drugs |
|
|
|
| |
|
|
|
|
